Although the herpes zoster (HZ) vaccine to decrease the incidence of Shingles was licensed for use in 2008, little coverage for HZ vaccination has occurred and stands nationally at 16%. At a targeted nursing home and assisted living facility, a protocol for including HZ along with state-mandated vaccinations was devised and used in screening incoming residents. Baseline data from chart reviews (n=122) showed that despite treatments given for the infection in the preceding 12 months, no vaccinations had occurred. During a 6-month implementation period, all new residents meeting eligibility criteria were offered the HZ vaccination. In this period, four residents agreed to the vaccination. In a pre to post implementation survey, all clinical providers (n = 9) indicated they had been (1) or would (8) would recommend the HZ vaccination.
Mbola, S. (2016). Protocol to Increase Administration of Herpes Zoster Vaccine in a Long-Term Care Facility. Journal of Nursing & Interprofessional Leadership in Quality & Safety, 1 (1). Retrieved from https://digitalcommons.library.tmc.edu/uthoustonjqualsafe/vol1/iss1/7